Irina Babina
Irina Babina is the CEO of Concr, a techbio company developing technology to predict patient response to therapeutics pre-clinically and clinically. She was previously a life sciences venture partner at Verve Ventures, in London.
- ‘Going into industry’ is still a dirty phrase for academia. We need to change thisOpinion
March 31, 2026
‘Going into industry’ is still a dirty phrase for academia. We need to change this